- Published at
- by manilatimes.net
mixed
mixed
News for Marinus Pharmaceuticals, Inc. (MRNS)
- Published at
- by gurufocus.com
positivepositiveVanguard Group Inc Reduces Holdings in Marinus Pharmaceuticals Inc
On December 31, 2024, Vanguard Group Inc made a strategic decision to reduce its holdings in Marinus Pharmaceuticals Inc (MRNS) by 206,197 shares. This transact- Published at
- by gurufocus.com
positivepositiveSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPY, HEES, MRNS on Behalf of Shareholders
PR NewswireNEW YORK, Jan. 15, 2025 NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co- Published at
- by zacks.com
neutralneutralMarinus Pharmaceuticals (MRNS) Upgraded to Buy: Here's What You Should Know
Marinus Pharmaceuticals (MRNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).- Published at
- by gurufocus.com
mixedmixedSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MRNS, RHE, SSY, CTV on Behalf of Shareholders
PR NewswireNEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp- Published at
- by gurufocus.com
positivepositiveSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o- Published at
- by gurufocus.com
positivepositiveSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA, LBRDA on Behalf of Shareholders
PR NewswireNEW YORK, Jan. 6, 2025 NEW YORK, Jan. 6, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp- Published at
- by gurufocus.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders
PR NewswireNEW YORK, Jan. 3, 2025 NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp- Published at
- by gurufocus.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders
NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o- Published at
- by gurufocus.com
positivepositiveImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
Immedica Pharma AB (Immedica), a leading global rare disease company, and [url="]Marinus Pharmaceuticals, Inc.[/url] (Nasdaq: MRNS), a pharmaceutical company c- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
mixedmixedU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.33% By Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.33%- Published at
- by benzinga.com
mixedmixedDow Falls 150 Points; Tesla Posts Upbeat Earnings - Tesla (NASDAQ:TSLA)
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 150 points on Thursday. Following the market opening Thursday, the Dow traded do...- Published at
- by investing.com
mixedmixedMarinus reports positive phase 3 seizure treatment trial results By Investing.com
Marinus reports positive phase 3 seizure treatment trial results- Published at
- by investing.com
mixedmixed3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
Stocks Analysis by MarketBeat.com (Leo Miller) covering: Comstock Mining Inc, Marinus Pharmaceuticals Inc, Amprius Technologies Inc. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com- Published at
- by investing.com
positivepositiveMarinus Pharmaceuticals' patent upheld by PTAB By Investing.com
Marinus Pharmaceuticals' patent upheld by PTAB- Published at
- by investing.com
mixedmixedOppenheimer sees upside for Marinus Pharmaceuticals stock ahead of key trial results By Investing.com
Oppenheimer sees upside for Marinus Pharmaceuticals stock ahead of key trial results- Published at
- by seekingalpha.com
mixedmixedPGIM Jennison Health Sciences Fund Q2 2024 Commentary
The PGIM Jennison Health Sciences Fund advanced and outperformed the index during June. Read more here.YIUNHD.BASPGI.MXSPGIREGN34.SAREGN.MXREGNNVON.MXNVONOVOBN.MXNOVC.DENOVA.DENONOFMRVIMRNSMRKD.BAMRK.SNMRK.PAMRK.MXMRKMHL.DELLY.MXLLY.DELLY.BALLYLILY34.SAHUM.MXCABAAMGN.MXAMGN.BAAMGNAMG.DEABBV34.SAABBV.MXABBV.BAABBV6MK.DE4AB.DE0TDD.L0R2M.L0Q1G.L0KYY.L0J6Z.LPRU.MXPRUP1DT34.SAISRG.MXISRGFRGAPAPLSALPN0R29.L0KRX.L- Published at
- by seekingalpha.com
mixedmixed- Published at
- by insidermonkey.com
mixedmixed10 Best Penny Stocks to Buy Under $1
Penny stocks are defined by the Securities and Exchange Commission (SEC) as stocks that trade for less than $5 per share. They exhibit high price volatility due to their low pricing.